FOXP3 defines regulatory t cells in human tumor and autoimmune disease

Cancer Research

Volumn 69, Issue 9, 2009, Pages 3995-4000

  Kryczek, Ilona ^a   Liu, Rebecca ^a   Wang, Guobin ^b   Wu, Ke ^a   Shu, Xiaogong ^b   Szeliga, Wojciech ^a   Vatan, Linhua ^a   Finlayson, Emily ^a   Huang, Emina ^a   Simeone, Diane ^a   Redman, Bruce ^a   Welling, Theodore H ^a   Chang, Alfred ^a   Zou, Weiping ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Union Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; INTERLEUKIN 10; PD 1 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CLINICAL ARTICLE; COLON CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; LIVER CARCINOMA; MELANOMA; MICROENVIRONMENT; OVARY CARCINOMA; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CYTOKINES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 65949111746     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3804     Document Type: Article

References (35)

1. + suppressor T cells:more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
2. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005; 5: 263-74.
3. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-52.
4. Von Herrath MG, Harrison LC. Regulatory lymphocytes:antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3: 223-32.
5. + regulatory T cells by TGF-βinduction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-86.
6. + regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A 2004; 101: 4572-7.
7. +CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172: 5149-53.
8. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T cells:FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006; 103: 6659-64.
9. Allan SE, Crome SQ, Crellin NK, et al. Activationinduced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345-54.
10. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-βdependent but does not confer a regulatory phenotype. Blood 2007; 110: 2983-90.
11. Kryczek I, Zou L, Rodriguez P, et al. B7-4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203: 871-81.
12. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-9.
13. + T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res 2007; 67: 7487-94.
14. Kryczek I, Wei S, Zou L, et al. Cutting edge:Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 2007; 178: 6730-3.
15. Kryczek I, Wei S, Zhu G, et al. Relationship between B7-4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007; 67: 8900-5.
16. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004; 64: 8451-5.
17. + regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A 2007; 104: 8029-34.
18. + regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res 2007; 13: 6947-58.
19. Zou W, Machelon V, Coulomb-L'Hermin A, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001; 7: 1339-46.
20. + regulatory T cells in human ovarian carcinoma. Cancer Res 2005; 65: 5020-6.
21. +CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004; 173: 3119-30.
22. high T cells in inflammatory bowel disease. Gastroenterology 2005; 128: 1868-78.
23. high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 2006; 12: 447-56.
24. + regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007; 13: 191-9.
25. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-9.
26. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004; 199: 1285-91.
27. high regulatory T cells in psoriasis:mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005; 174: 164-73.
28. Cao X, Cai SF, Fehniger TA, et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 2007; 27: 635-46.
29. Curiel TJ, Wei S, Dong H, et al. Blockade of B7-1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003; 21: 21.
30. Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008; 8: 467-77.
31. + T cell responses. J Exp Med 2007; 204: 1405-16.
32. Ahmadzadeh M, Felipe-Silva A, Heemskerk B, et al. FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions. Blood 2008; 112: 4953-60.
33. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61.
34. + regulatory T cells. Nat Immunol 2003; 4: 330-6.
35. + T regulatory cells. Nat Immunol 2003; 4: 337-42.